Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc.
The biotechnology sector is always volatile, and the recent market sell-off only makes it more so. Consequently, Alan Carr of Needham notes that …
In a research report released Friday, Needham’s healthcare analyst Alan Carr reiterated a Hold rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ahead of the company’s …
Needham’s healthcare analyst Alan Carr weighed in today with an update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), after the company reported first-quarter financial results and held a …
In a research report released this morning, Needham analyst Alan Carr reiterated a Hold rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ahead of the company’s …
